A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on Efficacy

Maruschka N Sluiter*, Ymkje Anna de Vries, Lotte G. Koning, Eelko Hak, Jens H. J. Bos, Catharina C. M. Schuiling-Veninga, Laura Batstra, Jeannette M. Doornenbal, Peter de Jonge

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

58 Downloads (Pure)

Abstract

Use of methylphenidate in children has increased substantially, despite conflicting evidence regarding efficacy. In this study, prescription data were analyzed in relation to the publication of new evidence regarding efficacy. Incidence rates and prescribed doses of methylphenidate increased, with a decline during the last few years. Duration of use is still increasing. In half of the cases, starting dosages are higher than recommended in guidelines. There was little evidence that publication of new evidence directly influenced the use of methylphenidate. Recent and critical study findings should receive more attention to contribute to the development and use of treatment guidelines for ADHD and evidence-based methylphenidate use.

Original languageEnglish
Pages (from-to)291–299
Number of pages9
JournalAdministration and Policy in Mental Health and Mental Health Services Research
Volume47
Issue number2
Early online date16-Oct-2019
DOIs
Publication statusPublished - Mar-2020

Keywords

  • FOLLOW-UP
  • STIMULANT MEDICATION
  • CHILDREN
  • ADOLESCENTS
  • OUTCOMES
  • ADHD

Cite this